Sudden perioperative death post aortic valve replacement with autopsy showing hypertrophic cardiomyopathy in elderly

Zubair Abdul Razak1, Joseph Westaby2, Mary N Sheppard3

  • 1Department of Forensic Medicine, Hospital Sultan Ismail, Johor Bahru, Malaysia.

Insights

A sudden perioperative death occurred after aortic valve replacement in a patient with previously undiagnosed hypertrophic cardiomyopathy (HCM). Autopsy confirmed HCM, emphasizing the need for family screening to prevent future sudden cardiac deaths.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pathology

Background:

  • Perioperative death is a significant concern for patients and surgical teams.
  • Autopsies are crucial for understanding unexpected perioperative fatalities.
  • This case involves a sudden death following aortic valve replacement in an elderly female with undiagnosed hypertrophic cardiomyopathy (HCM).

Purpose of the Study:

  • To report a rare case of sudden perioperative death due to undiagnosed hypertrophic cardiomyopathy (HCM) after aortic valve replacement (AVR).
  • To highlight the importance of autopsy in explaining unexpected post-operative deaths.
  • To underscore the need for genetic screening in families affected by HCM.

Main Methods:

  • A 73-year-old female underwent elective aortic valve replacement (AVR) for severe aortic valve stenosis (AS).
  • Despite successful surgery, the patient experienced persistent poor left ventricular function and died intraoperatively.
  • Post-mortem examination, including heart weight, left ventricular septal hypertrophy measurement, and left ventricular histology, was performed.

Main Results:

  • The patient died on the operating table due to unrecoverable poor left ventricular function post-AVR.
  • Histological examination revealed significant septal hypertrophy (20 mm) and myocyte disarray, confirming hypertrophic cardiomyopathy (HCM).
  • Aortic valve stenosis (AS) is a common indication for AVR, but sudden death can occur post-procedure.

Conclusions:

  • Undiagnosed hypertrophic cardiomyopathy (HCM) can lead to sudden unexpected death even after successful aortic valve replacement (AVR).
  • Autopsy plays a vital role in diagnosing conditions like HCM and providing closure for families.
  • Screening of family members is essential for inherited conditions like HCM to prevent further sudden cardiac deaths.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
287
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
470
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
412
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730